Unknown

Dataset Information

0

JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

ABSTRACT:

SUBMITTER: Tan LLY 

PROVIDER: S-EPMC8753315 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

Tan Laura Ling Ying LLY   Le Quynh-Thu QT   Lee Nancy Ying Ying NYY   Chua Melvin Lee Kiang MLK  

Cancer communications (London, England) 20211216 1

Similar Datasets

Unknown Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
| S-EPMC10685882 | biostudies-literature
Unknown Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
| S-EPMC8078488 | biostudies-literature
Unknown Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study.
| S-EPMC12859054 | biostudies-literature
Unknown Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
| S-EPMC5729473 | biostudies-literature
Unknown Combining interleukin 6 and EBV DNA levels predicts survival outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving chemoimmunotherapy.
| S-EPMC11949991 | biostudies-literature
Unknown Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review.
| S-EPMC9870248 | biostudies-literature
Unknown Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy.
| S-EPMC10798952 | biostudies-literature
Unknown Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma.
| S-EPMC11998246 | biostudies-literature
Unknown Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy.
| S-EPMC10594020 | biostudies-literature
Unknown A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment.
| S-EPMC9243306 | biostudies-literature